Daiichi Sankyo Espha, Japan-based generics subsidiary of Daiichi Sankyo, has launched three new generic drugs, Pramipexole hydrochloride 0.125mg tablets DSEP, Pramipexole hydrochloride 0.5mg tablets DSEP and Amlodipine 10mg tablets DSEP, with two active ingredients.
With original brand name of BI·Sifrol 0.125mg, 0.5mg tablets, Pramipexole hydrochloride 0.125mg tablets DSEP and Pramipexole hydrochloride 0.5mg tablets DSEP are dopamine agonists indicated for the treatment of Parkinson's disease.
Indicated for the treatment of hypertension and angina, the original brand name of calcium channel antagonist Amlodipine 10mg tablets DSEP is Norvasc 10mg tablets Amlodin 10mg tablets.
For simpler understanding of patients, the company also created new labeling on tablets and PTP sheets, which employ a material for blocking light yet allowing tablet visibility.
The product name and dosage on each pill, which is displayed through pitch control on both sides of the tablet, and special markings on both sides of the PTP sheets, allow easier identification of the tablets.
The GS1 data barcode marked on every tablet aids in the prevention of medication errors.
